Natco Pharma Deep Dive 🔍 0 Debt, Huge Cash 💰 But Should You Buy Now? 📊

Natco Pharma stock crashed from ₹1,638 to ₹726 — wiping out over 50% of investor wealth. Now it has recovered to around ₹1,029, and investors are asking the big question: 👉 Is Natco Pharma a buying opportunity or just a temporary bounce? In this video, we do a complete deep dive analysis of Natco Pharma (NSE: NATCOPHARM) using a value investing approach. 📊 What You’ll Learn in This Video: ✔️ Natco Pharma business model explained simply ✔️ Why the stock crashed 50% (Revlimid impact + Q3 shock + FDA news) ✔️ Cash flow analysis — are profits real or manipulated? ✔️ Debt breakdown — is Natco truly a zero-debt company? ✔️ Promoter quality & shareholding insights ✔️ Valuation analysis — cheap or fairly priced? ✔️ Future growth triggers (Semaglutide, Adcock Ingram, Demerger) ✔️ Technical analysis (Golden Crossover, Support & Resistance) ✔️ Risks you MUST consider before investing ✔️ Final verdict with exact BUY ZONE, STOP LOSS & TARGET 🎯 💡 Key Insights: • Strong cash flow — ₹1,697 Cr OCF vs ₹1,885 Cr profit • Zero promoter pledge — clean governance • Massive cash reserves vs very low debt • Short-term earnings decline due to Revlimid normalization • Long-term opportunity via GLP-1 (Semaglutide) and global expansion 🎯 My Verdict: 👉 ACCUMULATE in tranches Buy Zone: ₹950 – ₹1,050 Target: ₹1,300 – ₹1,500 (12–18 months) ⚠️ Risks to Watch: • Earnings decline in FY26–FY27 • US FDA inspection outcomes • Semaglutide patent/legal risks 📌 Disclaimer: This video is for educational purposes only. I am not a SEBI-registered investment advisor. Please do your own research before investing. 👍 If you found this useful: Like 👍 | Share 🔁 | Subscribe 🔔 For more deep-dive stock analysis based on real data. #natcopharma #stockmarketindia #indianstocks #stockanalysis #valueinvesting #multibaggerstocks #nseindia #pharmastocks #sharemarketindia #stockmarketforbeginners #investingindia #longterminvesting #stockmarkettips #fundamentalanalysis #technicalanalysis #smallcapstocks #midcapstocks #wealthcreation #indiainvesting #stocks2026